Delivery Order SPE2DB20D1100-SPE2DB25FE4F8
- Not listed
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $55,124.14 and an ultimate completion date of August 29, 2025. The contract involves no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $24,229.80 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract specifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $35,074.07 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 13, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $44,331.78. This firm fixed-price delivery order, which is not set-aside, was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract is valued at $59,442.23 and carries a firm fixed price structure with completion scheduled for September 11, 2025. The delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $31,982.02 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $14,017.54 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in units of 30 tablets. This is a firm fixed price contract with an ultimate completion date of September 17, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract, valued at $26,781.78, operates under a firm fixed-price arrangement with an ultimate completion date of May 1, 2025. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $33,897.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at AmerisourceBergen's facility in Conshohocken,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4F8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $17,009.72. This delivery order, which is competitively awarded with no set-aside designation, represents a firm fixed-price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a comprehensive indefinite delivery contract with DLA valued at $999,999,999.00 through December 2026, enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order for Biktarvy, an antiretroviral medication used in HIV treatment, exemplifies the breadth of pharmaceutical commodities the company delivers through the DLA Medical Supply Chain to support Defense Health Agency and other federal healthcare systems. The firm fixed-price delivery order structure and competitive award process demonstrate AmerisourceBergen's established capability to meet federal medical procurement requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 9/3/25 |